JAK inhibitors: an evidence-based choice of the most appropriate molecule

• Hlavní autoři: Luca Antonioli (Autor), Alessandro Armuzzi (Autor), Massimo C. Fantini (Autor), Matteo Fornai (Autor)
• Médium: Kniha
• Vydáno: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Janus kinase inhibitors (JAKis) represent a fundamental therapeutic tool for the treatment of patients with immune-mediated inflammatory diseases. Although JAKis are often considered a homogeneous class of drugs whose members are thought to be largely interchangeable, there are significant differenc...